It's not finished. That's not a fact that's your opinion. Iclusig certainly will play an important role in late stage cml or in patients with mutation. Tell me why it won't. Support your assertions
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.